REGISTERED
on 17 Dec 2019
Last Applicant/ Owned by
65 Hayden Avenue
Lexington
MA
02421
Serial Number
86783357 filed on 09th Oct 2015
Registration Number
5938245 registered on 17th Dec 2019
Correspondent Address
Christina Licursi
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
KALEIDO
preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointes Read More
Classification Information
Class [005]
Pharmaceutical Products
preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, infectious diseases, metabolic diseases, nutritional disorders, malnutrition, immune-mediated diseases, including autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, psychiatric conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, cardiovascular diseases, nephrologic diseases and conditions, including organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, including growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis
First Use Date in General
31st Jul 2019
First Use Date in Commerce
31st Jul 2019
Mark Details
Serial Number
No 86783357
Mark Type
No Service/Collective Mark
Attorney Docket Number
No V02792000100
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Dec 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 17th Dec 2019 | REGISTERED-PRINCIPAL REGISTER |
| 13th Nov 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 12th Nov 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 04th Nov 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| 02th Nov 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Oct 2019 | USE AMENDMENT FILED |
| 18th Oct 2019 | TEAS STATEMENT OF USE RECEIVED |
| 25th Apr 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 23rd Apr 2019 | SOU EXTENSION 1 FILED |